Differentiating benign from malignant thyroid nodules is essential for effective patient management.
Purpose
To evaluate the diagnostic performance of contrast-enhanced ultrasound (CEUS) for thyroid nodule characterization based on currently available evidence.
Material and Methods
We conducted a systematic review and meta-analysis of studies evaluating the diagnostic accuracy of CEUS for thyroid nodules. PubMed, Scopus, and Web of Science were searched through 31 March 2025. Studies using histopathologic or cytologic reference standards were included. Pooled estimates of sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy were calculated using random-effects models. Subgroup analyses and meta-regression were performed to explore potential effect modifiers. Studies evaluating contrast-enhanced computed tomography were included in the qualitative synthesis but were not incorporated into the quantitative meta-analysis.
Results
A total of 59 studies were included in the systematic review. Among these, 54 CEUS studies provided sufficient data for quantitative synthesis. CEUS demonstrated pooled sensitivity of 78.6% and specificity of 82.6%, with an overall diagnostic accuracy of 81.6%. Subgroup analyses indicated that examiner experience significantly influenced diagnostic performance, with higher sensitivity observed in studies involving more experienced operators. Meta-regression did not identify statistically significant independent associations between examined covariates and diagnostic outcomes.
Conclusion
The available literature indicates that CEUS demonstrates favorable diagnostic performance for differentiating benign from malignant thyroid nodules. Further prospective studies using standardized imaging protocols and reporting frameworks are needed to better define the role of CEUS in thyroid nodule evaluation.
DeanDSGharibH. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab2008;22:901–911.
2.
UlusoyB. The Management of Thyroid Nodules. Turk Arch Otorhinolaryngol2015;53:173.
3.
ShuzhenC. Comparison analysis between conventional ultrasonography and ultrasound elastography of thyroid nodules. Eur J Radiol2012;81:1806–1811.
4.
RagoTVittiP. Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules. Best Pract Res Clin Endocrinol Metab2008;22:913–928.
5.
SchlederSJankeMAghaA, et al.Preoperative differentiation of thyroid adenomas and thyroid carcinomas using high resolution contrast-enhanced ultrasound (CEUS). Clin Hemorheol Microcirc2015;61:13–22.
6.
ZhangJZhangXMengY, et al.Contrast-enhanced ultrasound for the differential diagnosis of thyroid nodules: An updated meta-analysis with comprehensive heterogeneity analysis. PLoS One2020;15:e0231775.
7.
MishraAPradhanPKGambhirS, et al.Preoperative contrast-enhanced computerized tomography should not delay radioiodine ablation in differentiated thyroid carcinoma patients. J Surg Res2015;193:731–737.
8.
ZhaoSYueWWangH, et al.Combined conventional ultrasound and contrast-enhanced computed tomography for cervical lymph node metastasis prediction in papillary thyroid carcinoma. J Ultrasound Med2023;42:385–398.
9.
TrimboliPCastellanaMViriliC, et al.Performance of contrast-enhanced ultrasound (CEUS) in assessing thyroid nodules: a systematic review and meta-analysis using histological standard of reference. Radiol Med2020;125:406–415.
10.
DingYPengYZhangJ, et al.Diagnostic value of contrast-enhanced ultrasound in the diagnosis of papillary thyroid microcarcinoma: A systematic review and meta-analysis. Medicine (Baltimore)2024;103:e37768.
11.
LiQLMaTWangZJ, et al.The value of contrast-enhanced ultrasound for the diagnosis of metastatic cervical lymph nodes of papillary thyroid carcinoma: A systematic review and meta-analysis. J Clin Ultrasound2022;50:60–69.
12.
PageMJMcKenzieJEBossuytPM, et al.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ2021;372:n71.
13.
MukaTGlisicMMilicJ, et al.A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research. Eur J Epidemiol2020;35:49–60.
SterneJAHernánMAReevesBC, et al.ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ2016;355:i4919.
16.
SterneJASavovićJPageMJ, et al.RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ2019;366:i4898.
17.
BorleaAMoisa-LucaLPopescuA, et al.Combining CEUS and ultrasound parameters in thyroid nodule and cancer diagnosis: a TIRADS-based evaluation. Front Endocrinol (Lausanne)2024;15:1417449.
18.
BrandensteinMWiesingerIKünzelJ, et al.Multiparametric sonographic imaging of thyroid lesions: chances of B-mode, elastography and CEUS in relation to preoperative histopathology. Cancers (Basel)2022;14:4745.
19.
CantisaniVConsortiFGuerrisiA, et al.Prospective comparative evaluation of quantitative-elastosonography (Q-elastography) and contrast-enhanced ultrasound for the evaluation of thyroid nodules: preliminary experience. Eur J Radiol2013;82:1892–1898.
20.
CaoDZouRZhangM, et al.Sonographic characteristics of thyroid nodules with a Halo. Thyroid Res2024;17:20.
21.
ChenJHZhangYQZhuTT, et al.Applying machine-learning models to differentiate benign and malignant thyroid nodules classified as C-TIRADS 4 based on 2D-ultrasound combined with five contrast-enhanced ultrasound key frames. Front Endocrinol (Lausanne)2024;15:1299686.
22.
ChenLChenLLiangZ, et al.Value of contrast-enhanced ultrasound in the preoperative evaluation of papillary thyroid carcinoma invasiveness. Front Oncol2021;11:795302.
23.
ChenMZhangKQXuYF, et al.Shear wave elastography and contrast-enhanced ultrasonography in the diagnosis of thyroid malignant nodules. Mol Clin Oncol2016;5:724–730.
24.
DengJZhouPTianSM, et al.Comparison of diagnostic efficacy of contrast-enhanced ultrasound, acoustic radiation force impulse imaging, and their combined use in differentiating focal solid thyroid nodules. PLoS One2014;9:e90674.
25.
DiaoXZhanJChenL, et al.Quantification of solid hypo-echoic thyroid nodule enhancement with contrast-enhanced ultrasound. Transl Cancer Res2017;6:1078–1087
26.
FanJTaoLZhanW, et al.Diagnostic value of qualitative and quantitative parameters of contrast-enhanced ultrasound for differentiating differentiated thyroid carcinomas from benign nodules. Front Endocrinol (Lausanne)2023;14:1240615.
27.
GiustiMOrlandiDMelleG, et al.Is there a real diagnostic impact of elastosonography and contrast-enhanced ultrasonography in the management of thyroid nodules?J Zhejiang Univ Sci B2013;14:195–206.
28.
GuoSYZhouPZhangY, et al.Exploring the value of radiomics features based on B-mode and contrast-enhanced ultrasound in discriminating the nature of thyroid nodules. Front Oncol2021;11:738909.
29.
GuoWBaiWLiuJ, et al.Can contrast-enhancement computed tomography texture and histogram analyses help to differentiate malignant from benign thyroid nodules?Jpn J Radiol2020;38:1135–1141.
30.
HeYWangXYHuQ, et al.Value of contrast-enhanced ultrasound and acoustic radiation force impulse imaging for the differential diagnosis of benign and malignant thyroid nodules. Front Pharmacol2018;9:1363.
31.
HuangKBaiZBianD, et al.Diagnostic accuracy of contrast-enhanced ultrasonography in papillary thyroid microcarcinoma stratified by size. Ultrasound Med Biol2020;46:269–274.
32.
HuaqunZXuelingLBeiL, et al.Advantages of the Korean Thyroid Imaging Reporting and Data System combined with contrast-enhanced ultrasound in diagnosing papillary thyroid microcarcinoma. Iran J Radiol2019;16:e83460.
33.
JainulabdeenTRamaswamyBDevarajaK, et al.Preoperative staging of differentiated thyroid carcinomas: comparison of USG and CT with intraoperative findings and histopathology. Indian J Otolaryngol Head Neck Surg2019;71:327–333.
34.
JiangJShangXWangH, et al.Diagnostic value of contrast-enhanced ultrasound in thyroid nodules with calcification. Kaohsiung J Med Sci2015;31:138–144.
35.
JiangJShangXZhangH, et al.Correlation between maximum intensity and microvessel density for differentiation of malignant from benign thyroid nodules on contrast-enhanced sonography. J Ultrasound Med2014;33:1257–1263.
36.
JinLXuCXieX, et al.An algorithm of image heterogeneity with contrast-enhanced ultrasound in differential diagnosis of solid thyroid nodules. Ultrasound Med Biol2017;43:104–110.
37.
JinZZhuYLeiY, et al.Clinical application of C-TIRADS category and contrast-enhanced ultrasound in differential diagnosis of solid thyroid nodules measuring ≥1 cm. Med Sci Monit2022;28:e936368.
38.
LiFLuoH. Comparative study of thyroid puncture biopsy guided by contrast-enhanced ultrasonography and conventional ultrasound. Exp Ther Med2013;5:1381–1384.
39.
LiFWangYBaiB, et al.Advantages of routine ultrasound combined with contrast-enhanced ultrasound in diagnosing papillary thyroid carcinoma. Ultrasound Q2017;33:213–218.
40.
LiFZhangJWangY, et al.Clinical value of elasticity imaging and contrast-enhanced ultrasound in the diagnosis of papillary thyroid microcarcinoma. Oncol Lett2015;10:1371–1377.
41.
LiRRuanJLuY. Dual-modality watershed fusion network for thyroid nodule classification of dual-view CEUS video. In: Medical Image Computing and Computer Assisted Intervention - MICCAI 2024. Lecture Notes in Computer Science. Vol. 15005. Cham: Springer, 2024, pp.220–229.
42.
LiTMaoLWangX, et al.Ring-enhancement on CEUS: is it useful in the differential diagnosis of solid thyroid nodules?Ultrason Imaging2025;47:37–44.
43.
LiXGaoFLiF, et al.Qualitative analysis of contrast-enhanced ultrasound in the diagnosis of small, TR3-5 benign and malignant thyroid nodules measuring ≤1 cm. Br J Radiol2020;93:20190923.
44.
LinZMWenQYanCX, et al.Combination of contrast-enhanced ultrasound and strain elastography to assess cytologically non-diagnostic thyroid nodules. Oncol Lett2019;18:6845–6851.
45.
LiuMJMenYMZhangYL, et al.Improvement of diagnostic efficiency in distinguishing the benign and malignant thyroid nodules via conventional ultrasound combined with ultrasound contrast and elastography. Oncol Lett2017;14:867–871.
46.
LiuQOuyangLZhangS, et al.Comparison of the value of ultrasound-guided fine needle aspiration biopsy and contrast-enhanced ultrasound in different sizes of thyroid nodules. Medicine (Baltimore)2024;103:e39843.
47.
LuoWYangXYuanJ, et al.Evaluation of characteristics of thyroid nodules on contrast-enhanced ultrasonography: a retrospective analysis of 252 cases. Med Ultrason2020;22:164–170.
48.
MaHJYangJCLengZP, et al.Preoperative prediction of papillary thyroid microcarcinoma via multiparameter ultrasound. Acta Radiol2017;58:1303–1311.
49.
NemecUNemecSFNovotnyC, et al.Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy. Eur Radiol2012;22:1357–1365.
50.
PetrasovaHSlaisovaRRohanT, et al.Contrast-enhanced ultrasonography for differential diagnosis of benign and malignant thyroid lesions: single-institutional prospective study of qualitative and quantitative CEUS characteristics. Contrast Media Mol Imaging2022;2022:8229445.
51.
PrieditisPRadzinaMStrumfaI, et al.Diagnostic value of contrast-enhanced ultrasound evaluation of malignant and benign solitary thyroid nodules. Proceedings of the Latvian Academy of Sciences2016;70:1–6.
52.
SuiXLiuHJJiaHL, et al.Contrast-enhanced ultrasound and real-time elastography in the differential diagnosis of malignant and benign thyroid nodules. Exp Ther Med2016;12:783–791.
53.
TianQZhuHLiH. Significance of contrast-enhanced ultrasonography in differential diagnosis of thyroid nodules. Medicine (Baltimore)2018;97:e12688.
54.
VermaAKrishnaKAKumarI, et al.Integrated use of contrast-enhanced and grey-scale ultrasound in assigning American College of Radiology Thyroid Imaging-Reporting and Data System scores for characterisation of thyroid nodules: a prospective observational study. Ultrasound2024;32:140–149.
55.
WangBOuXYangJ, et al.Contrast-enhanced ultrasound and shear wave elastography in the diagnosis of ACR TI-RADS 4 and 5 category thyroid nodules coexisting with Hashimoto’s thyroiditis. Front Oncol2022;12:1022305.
56.
WangYDongTNieF, et al.Contrast-enhanced ultrasound in the differential diagnosis and risk stratification of ACR TI-RADS category 4 and 5 thyroid nodules with non-hypovascular. Front Oncol2021;11:662273.
57.
WuQWangYLiY, et al.Diagnostic value of contrast-enhanced ultrasound in solid thyroid nodules with and without enhancement. Endocrine2016;53:480–488.
58.
XiXGaoLWuQ, et al.Differentiation of thyroid nodules difficult to diagnose with contrast-enhanced ultrasonography and real-time elastography. Front Oncol2020;10:112.
59.
XuYQiXZhaoX, et al.Clinical diagnostic value of contrast-enhanced ultrasound and TI-RADS classification for benign and malignant thyroid tumors: one comparative cohort study. Medicine (Baltimore)2019;98:e14051.
60.
YangWZhouJYueC, et al.Clinical value of contrast-enhanced ultrasound quantitative analysis for differentiating thyroid lesions in Hashimoto’s thyroiditis patients. Quant Imaging Med Surg2024;14:944–957.
61.
YuanXWenHHuangM, et al.A clinical retrospective study on the qualitative value of multimodal ultrasonography for ACR-TIRADS 4 thyroid nodules ranging from 1 cm to 1.5 cm. Technol Cancer Res Treat2024;23:15330338241297599.
62.
YuanZQuanJYunxiaoZ, et al.Contrast-enhanced ultrasound in the diagnosis of solitary thyroid nodules. J Cancer Res Ther2015;11:41–45.
63.
ZhangBJiangYXLiuJB, et al.Utility of contrast-enhanced ultrasound for evaluation of thyroid nodules. Thyroid2010;20:51–57.
64.
ZhangJWangZGuoP. Correlations of contrast-enhanced ultrasound parameters with free thyroxine, total thyroxine, thyroid peroxidase antibody and thyroglobulin antibody in patients with thyroid nodules. Revista Romana de Medicina de Laborator2023;31:275–284.
65.
ZhangYLuoYKZhangMB, et al.Diagnostic accuracy of contrast-enhanced ultrasound enhancement patterns for thyroid nodules. Med Sci Monit2016;22:4755–4764.
66.
ZhangYZhangMBLuoYK, et al.The value of peripheral enhancement pattern for diagnosing thyroid cancer using contrast-enhanced ultrasound. Int J Endocrinol2018;2018:1625958.
67.
ZhangYZhouPTianSM, et al.Usefulness of combined use of contrast-enhanced ultrasound and TI-RADS classification for the differentiation of benign from malignant lesions of thyroid nodules. Eur Radiol2017;27:1527–1536.
68.
ZhaoHLiuXLeiB, et al.Impact of thyroid nodule sizes on the diagnostic performance of Korean thyroid imaging reporting and data system and contrast-enhanced ultrasound. Clin Hemorheol Microcirc2019;72:317–326.
69.
ZhaoHLiuXLeiB, et al.Diagnostic performance of thyroid imaging reporting and data system (TI-RADS) alone and in combination with contrast-enhanced ultrasonography for the characterization of thyroid nodules. Clin Hemorheol Microcirc2019;72:95–106.
70.
ZhaoLZhaoLChenH, et al.Diagnostic value of FNA, ultrasound elastography and CEUS in thyroid carcinoma. Afr Health Sci2024;24:188–193.
71.
ZhuTChenJZhouZ, et al.Differentiation of thyroid nodules (C-TIRADS 4) by combining contrast-enhanced ultrasound diagnosis model with Chinese Thyroid Imaging Reporting and Data System. Front Oncol2022;12:840819.
72.
HuangS-TZhangBYinH-L, et al.Incremental diagnostic value of shear wave elastography combined with contrast-enhanced ultrasound in TI-RADS category 4a and 4b nodules. J Med Ultrason (2001)2020;47:453–462.
73.
LiH-JSuiG-QTengD-K, et al.Incorporation of CEUS and SWE parameters into a multivariate logistic regression model for the differential diagnosis of benign and malignant TI-RADS 4 thyroid nodules. Endocrine2024;83:691–699.
74.
LiuJLiuLZhangY, et al.Analysis of characteristics microvessel density of thyroid malignant and benign nodules on contrast-enhanced ultrasonography. Adv Ultrasound Diag Therap2018;2:167–172.
75.
YuDHanYChenT. Contrast-enhanced ultrasound for differentiation of benign and malignant thyroid lesions: meta-analysis. Otolaryngol Head Neck Surg2014;151:909–915.
76.
SunBLangLZhuX, et al.Accuracy of contrast-enhanced ultrasound in the identification of thyroid nodules: a meta-analysis. Int J Clin Exp Med2015;8:12882.
77.
NemecUNemecSFNovotnyC, et al.Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy. Eur Radiol2012;22:1357–1365.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
